PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$27.51
-4.23%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$56.25
Range $50.00 – $60.00
Implied Upside
+104.5%
Consensus $56.25 vs current $27.51
AMEX·Healthcare·Biotechnology
$27.51
-4.23%
Mkt Cap $15.45M
No recent rating data.
Price Target (6 analysts)
$56.25
Range $50.00 – $60.00
+104.5%
Consensus $56.25 vs current $27.51